Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Ganeshan, K. & Chawla, A. Metabolic regulation of immune responses. Annu. Rev. Immunol. 32, 609–634 (2014).
Google Scholar
Ning, L., Shishi, Z., Bo, W. & Huiqing, L. Targeting immunometabolism against acute lung injury. Clin. Immunol. 249, 109289 (2023).
Google Scholar
Mathis, D. & Shoelson, S. E. Immunometabolism: an emerging frontier. Nat. Rev. Immunol. 11, 81 (2011).
Google Scholar
Fullerton, M. D., Steinberg, G. R. & Schertzer, J. D. Immunometabolism of AMPK in insulin resistance and atherosclerosis. Mol. Cell Endocrinol. 366, 224–234 (2013).
Google Scholar
Schipper, H. S., Prakken, B., Kalkhoven, E. & Boes, M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 23, 407–415 (2012).
Google Scholar
Martinez-Santibañez, G. & Lumeng, C. N. Macrophages and the regulation of adipose tissue remodeling. Annu. Rev. Nutr. 34, 57–76 (2014).
Google Scholar
Rathmell, J. C. Metabolism and autophagy in the immune system: immunometabolism comes of age. Immunol. Rev. 249, 5–13 (2012).
Google Scholar
Pearce, E. L. & Pearce, E. J. Metabolic pathways in immune cell activation and quiescence. Immunity 38, 633–643 (2013).
Google Scholar
Mockler, M. B., Conroy, M. J. & Lysaght, J. Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment. Front. Oncol. 4, 107 (2014).
Google Scholar
Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).
Google Scholar
Silveira Rossi, J. L. et al. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diab. Metab. Res. Rev. 38, e3502 (2022).
Google Scholar
Kelly, B. & O’Neill, L. A. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771–784 (2015).
Google Scholar
Mantovani, A. et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555 (2002).
Google Scholar
Zhu, L. et al. Cellular metabolism and macrophage functional polarization. Int Rev. Immunol. 34, 82–100 (2015).
Google Scholar
Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677–686 (2004).
Google Scholar
Zhang, Q. & Sioud, M. Tumor-associated macrophage subsets: shaping polarization and targeting. Int. J. Mol. Sci. 24, 7493 (2023).
Google Scholar
Nakai, K. Multiple roles of macrophage in skin. J. Dermatol Sci. 104, 2–10 (2021).
Google Scholar
Arora, S. et al. Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology 223, 383–396 (2018).
Google Scholar
Huang, X., Li, Y., Fu, M. & Xin, H. B. Polarizing macrophages in vitro. Methods Mol. Biol. 1784, 119–126 (2018).
Google Scholar
Colin, S., Chinetti-Gbaguidi, G. & Staels, B. Macrophage phenotypes in atherosclerosis. Immunol. Rev. 262, 153–166 (2014).
Google Scholar
Viola, A. et al. The metabolic signature of macrophage responses. Front. Immunol. 10, 1462 (2019).
Google Scholar
Van den Bossche, J., O’Neill, L. A. & Menon, D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 38, 395–406 (2017).
Google Scholar
Warburg, O., Gawehn, K. & Geissler, A. W. Metabolism of leukocytes. Z. Naturforsch. B 13b, 515–516 (1958).
Google Scholar
Warburg, O., Negelein, E. & Posener, K. Versuche an überlebendem Ca. Gewebe. Klin. Wochenschr (1923).
Warburg, O., Posener, K. & Negelein, E. Über den stoffwechsel der carcinomzelle. Naturwissenschaften 12, 1131–1137 (1924).
Google Scholar
Vaupel, P. & Multhoff, G. Revisiting the Warburg effect: historical dogma versus current understanding. J. Physiol. 599, 1745–1757 (2021).
Google Scholar
Wang, N. et al. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma. Signal Transduct. Target. Ther. 6, 86 (2021).
Google Scholar
Barros, L. F. et al. Aerobic glycolysis in the brain: warburg and crabtree contra pasteur. Neurochem. Res. 46, 15–22 (2021).
Google Scholar
Vallée, A., Lecarpentier, Y., Guillevin, R. & Vallée, J. N. Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease. Rev. Neurosci. 29, 547–555 (2018).
Google Scholar
Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251 (2013).
Google Scholar
Minton, K. Immunometabolism: what is the point of warburg? Nat. Rev. Immunol. 13, 472 (2013).
Google Scholar
Poznanski, S. M., Barra, N. G., Ashkar, A. A. & Schertzer, J. D. Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function. Inflamm. Res. 67, 813–828 (2018).
Google Scholar
Krejčová, G. et al. Drosophila macrophages switch to aerobic glycolysis to mount effective antibacterial defense. Elife 8, e50414 (2019).
Google Scholar
Yuan, Y. et al. The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis. Cell Mol. Immunol. 19, 504–515 (2022).
Google Scholar
Wang, T. et al. HIF1α-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediat. Inflamm. 2017, 9029327 (2017).
Google Scholar
Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013).
Google Scholar
Kim, Y. J. et al. Cassiaside C inhibits M1 polarization of macrophages by downregulating glycolysis. Int J. Mol. Sci. 23, 1696 (2022).
Google Scholar
Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 21, 65–80 (2015).
Google Scholar
Wang, J. et al. Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages. Int. J. Biol. Sci. 18, 6210–6225 (2022).
Google Scholar
O’Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213, 15–23 (2016).
Google Scholar
Williams, N. C. & O’Neill, L. A. J. A role for the krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front. Immunol. 9, 141 (2018).
Google Scholar
Wu, J. Y. et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol. Cell 77, 213–227.e215 (2020).
Google Scholar
Duan, J. X. et al. Extracellular citrate serves as a DAMP to activate macrophages and promote LPS-induced lung injury in mice. Int. Immunopharmacol. 101, 108372 (2021).
Google Scholar
Wu, X. et al. Metabolic control during macrophage polarization by a citrate-functionalized scaffold for maintaining bone homeostasis. Adv. Healthc. Mater. e2400770 (2024). https://doi.org/10.1002/adhm.202400770.
Collins, S. L. et al. mTORC1 signaling regulates proinflammatory macrophage function and metabolism. J. Immunol. 207, 913–922 (2021).
Google Scholar
Rao, J. et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut 71, 2539–2550 (2022).
Google Scholar
Zhang, Y. et al. M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2/HIF-1α axis mediated metabolic reprogramming of macrophages. Redox Biol. 69, 103016 (2024).
Google Scholar
Nagy, C. & Haschemi, A. Time and demand are two critical dimensions of immunometabolism: the process of macrophage activation and the pentose phosphate pathway. Front. Immunol. 6, 164 (2015).
Google Scholar
Dionísio, F., Tomas, L. & Schulz, C. Glycolytic side pathways regulating macrophage inflammatory phenotypes and functions. Am. J. Physiol. Cell Physiol. 324, C558–c564 (2023).
Google Scholar
He, D. et al. Pentose phosphate pathway regulates tolerogenic apoptotic cell clearance and immune tolerance. Front. Immunol. 12, 797091 (2021).
Google Scholar
Nakamizo, S. et al. Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. J. Clin. Investig. 133, e171088 (2023).
Google Scholar
Wculek, S. K. et al. Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis. Immunity 56, 516–530.e519 (2023).
Google Scholar
Wang, F. et al. Glycolytic stimulation is not a requirement for m2 macrophage differentiation. Cell Metab. 28, 463–475.e464 (2018).
Google Scholar
Dang, C. P. & Leelahavanichkul, A. Over-expression of miR-223 induces M2 macrophage through glycolysis alteration and attenuates LPS-induced sepsis mouse model, the cell-based therapy in sepsis. PLoS One 15, e0236038 (2020).
Google Scholar
Yan, J. & Horng, T. Lipid metabolism in regulation of macrophage functions. Trends Cell Biol. 30, 979–989 (2020).
Google Scholar
Batista-Gonzalez, A., Vidal, R., Criollo, A. & Carreño, L. J. New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages. Front. Immunol. 10, 2993 (2019).
Google Scholar
Wu, L. et al. RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis. Cancer Immunol. Res. 8, 710–721 (2020).
Google Scholar
Nomura, M. et al. Fatty acid oxidation in macrophage polarization. Nat. Immunol. 17, 216–217 (2016).
Google Scholar
Li, X. et al. Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance. Cell Rep. 36, 109607 (2021).
Google Scholar
Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015).
Google Scholar
Hu, X. et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun.43, 909–937 (2023).
Google Scholar
Zhu, Y. et al. Cigarette smoke promotes oral leukoplakia via regulating glutamine metabolism and M2 polarization of macrophage. Int. J. Oral. Sci. 13, 25 (2021).
Google Scholar
Zhu, Y. et al. Glutamine mitigates murine burn sepsis by supporting macrophage M2 polarization through repressing the SIRT5-mediated desuccinylation of pyruvate dehydrogenase. Burns Trauma 10, tkac041 (2022).
Google Scholar
Liu, P. S. et al. α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat. Immunol. 18, 985–994 (2017).
Google Scholar
Shang, M. et al. Macrophage-derived glutamine boosts satellite cells and muscle regeneration. Nature 587, 626–631 (2020).
Google Scholar
Wang, C. et al. Serine synthesis sustains macrophage IL-1β production via NAD(+)-dependent protein acetylation. Mol. Cell 84, 744–759.e746 (2024).
Google Scholar
Shan, X. et al. Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis. Cell Mol. Immunol. 19, 1263–1278 (2022).
Google Scholar
Rodriguez, A. E. et al. Serine metabolism supports macrophage IL-1β production. Cell Metab. 29, 1003–1011.e1004 (2019).
Google Scholar
Ouyang, Y. et al. FGFR3 alterations in bladder cancer stimulate serine synthesis to induce immune-inert macrophages that suppress t-cell recruitment and activation. Cancer Res. 83, 4030–4046 (2023).
Google Scholar
Li, J. et al. Crocin alleviates coronary atherosclerosis via inhibiting lipid synthesis and inducing M2 macrophage polarization. Int. Immunopharmacol. 55, 120–127 (2018).
Google Scholar
Meana, C. et al. Lipin-1 integrates lipid synthesis with proinflammatory responses during TLR activation in macrophages. J. Immunol. 193, 4614–4622 (2014).
Google Scholar
Lee, J. H. et al. SREBP-1a-stimulated lipid synthesis is required for macrophage phagocytosis downstream of TLR4-directed mTORC1. Proc. Natl Acad. Sci. USA 115, E12228–e12234 (2018).
Google Scholar
Almeida, L., Lochner, M., Berod, L. & Sparwasser, T. Metabolic pathways in T cell activation and lineage differentiation. Semin. Immunol. 28, 514–524 (2016).
Google Scholar
Kidani, Y. et al. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat. Immunol. 14, 489–499 (2013).
Google Scholar
Xu, X. et al. Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway. Cell Death Dis. 8, e2723 (2017).
Google Scholar
Pinzon Grimaldos, A. et al. The role of lipid metabolism in shaping the expansion and the function of regulatory T cells. Clin. Exp. Immunol. 208, 181–192 (2022).
Google Scholar
van den Broek, T., Borghans, J. A. M. & van Wijk, F. The full spectrum of human naive T cells. Nat. Rev. Immunol. 18, 363–373 (2018).
Google Scholar
Chen, H., Yang, T., Zhu, L. & Zhao, Y. Cellular metabolism on T-cell development and function. Int. Rev. Immunol. 34, 19–33 (2015).
Google Scholar
Angelin, A. et al. Foxp3 reprograms T Cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282–1293.e1287 (2017).
Google Scholar
Raud, B. et al. Fatty acid metabolism in CD8(+) T cell memory: challenging current concepts. Immunol. Rev. 283, 213–231 (2018).
Google Scholar
Cribioli, E. et al. Enforcing GLUT3 expression in CD8(+) T cells improves fitness and tumor control by promoting glucose uptake and energy storage. Front. Immunol. 13, 976628 (2022).
Google Scholar
Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769–777 (2002).
Google Scholar
Macintyre, A. N. et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61–72 (2014).
Google Scholar
Zhang, H. et al. TCR activation directly stimulates PYGB-dependent glycogenolysis to fuel the early recall response in CD8(+) memory T cells. Mol. Cell 82, 3077–3088.e3076 (2022).
Google Scholar
Shan, J., Jin, H. & Xu, Y. T cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus. Front. Immunol. 11, 1027 (2020).
Google Scholar
Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Investig. 125, 194–207 (2015).
Google Scholar
Zhang, S. et al. The alterations in and the role of the Th17/treg balance in metabolic diseases. Front Immunol. 12, 678355 (2021).
Google Scholar
Lou, W. et al. Lipid metabolic features of T cells in the tumor microenvironment. Lipids Health Dis. 21, 94 (2022).
Google Scholar
Kim, Y. C. & Guan, K. L. mTOR: a pharmacologic target for autophagy regulation. J. Clin. Investig. 125, 25–32 (2015).
Google Scholar
Huang, H. et al. mTOR signaling at the crossroads of environmental signals and T-cell fate decisions. Immunol. Rev. 295, 15–38 (2020).
Google Scholar
Lochner, M., Berod, L. & Sparwasser, T. Fatty acid metabolism in the regulation of T cell function. Trends Immunol. 36, 81–91 (2015).
Google Scholar
Angela, M. et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells. Nat. Commun. 7, 13683 (2016).
Google Scholar
Chyau, C. C. et al. Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL/6 mice model via AMPK/Sirt1/SREBP-1c/PPARγ pathway. Int J. Mol. Sci. 21, 360 (2020).
Google Scholar
Teresi, R. E., Planchon, S. M., Waite, K. A. & Eng, C. Regulation of the PTEN promoter by statins and SREBP. Hum. Mol. Genet. 17, 919–928 (2008).
Google Scholar
Maciolek, J. A., Pasternak, J. A. & Wilson, H. L. Metabolism of activated T lymphocytes. Curr. Opin. Immunol. 27, 60–74 (2014).
Google Scholar
Pan, Y. et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543, 252–256 (2017).
Google Scholar
Endo, Y., Kanno, T. & Nakajima, T. Fatty acid metabolism in T-cell function and differentiation. Int. Immunol. 34, 579–587 (2022).
Google Scholar
Barbi, J., Pardoll, D. & Pan, F. Treg functional stability and its responsiveness to the microenvironment. Immunol. Rev. 259, 115–139 (2014).
Google Scholar
Pereira, J. A. et al. PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis. Front. Immunol. 14, 997376 (2023).
Google Scholar
Wang, W. & Zou, W. Amino acids and their transporters in T cell immunity and cancer therapy. Mol. Cell 80, 384–395 (2020).
Google Scholar
Ron-Harel, N. et al. T cell activation depends on extracellular alanine. Cell Rep. 28, 3011–3021.e3014 (2019).
Google Scholar
Geiger, R. et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167, 829–842.e813 (2016).
Google Scholar
Vinogradova, E. V. et al. An activity-guided map of electrophile-cysteine interactions in primary human T cells. Cell 182, 1009–1026.e1029 (2020).
Google Scholar
Nakaya, M. et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40, 692–705 (2014).
Google Scholar
Ananieva, E. A., Powell, J. D. & Hutson, S. M. Leucine metabolism in T cell activation: mTOR signaling and beyond. Adv. Nutr. 7, 798s–805s (2016).
Google Scholar
Roy, D. G. et al. Methionine metabolism shapes t helper cell responses through regulation of epigenetic reprogramming. Cell Metab. 31, 250–266.e259 (2020).
Google Scholar
Ma, E. H. et al. Serine is an essential metabolite for effector t cell expansion. Cell Metab. 25, 345–357 (2017).
Google Scholar
Pieper, K., Grimbacher, B. & Eibel, H. B-cell biology and development. J. Allergy Clin. Immunol. 131, 959–971 (2013).
Google Scholar
Prieto, J. M. B. & Felippe, M. J. B. Development, phenotype, and function of non-conventional B cells. Comp. Immunol. Microbiol. Infect. Dis. 54, 38–44 (2017).
Google Scholar
Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607–612 (2015).
Google Scholar
Raza, I. G. A. & Clarke, A. J. B. Cell metabolism and autophagy in autoimmunity. Front. Immunol. 12, 681105 (2021).
Google Scholar
Frasca, D. & Blomberg, B. B. Obesity accelerates age defects in mouse and human B cells. Front. Immunol. 11, 2060 (2020).
Google Scholar
Chapman, N. M. & Chi, H. Metabolic adaptation of lymphocytes in immunity and disease. Immunity 55, 14–30 (2022).
Google Scholar
Boothby, M. & Rickert, R. C. Metabolic regulation of the immune humoral response. Immunity 46, 743–755 (2017).
Google Scholar
Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626–3636 (2014).
Google Scholar
Cambier, J. C., Gauld, S. B., Merrell, K. T. & Vilen, B. J. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7, 633–643 (2007).
Google Scholar
Galicia-Vázquez, G. & Aloyz, R. Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: how much do we actually know? Crit. Rev. Oncol. Hematol. 134, 65–70 (2019).
Google Scholar
Noble, R. A. et al. Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma. Br. J. Cancer 127, 937–947 (2022).
Google Scholar
Weisel, F. J. et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat. Immunol. 21, 331–342 (2020).
Google Scholar
Zhou, C. J. et al. Short-chain fatty acids promote immunotherapy by modulating immune regulatory property in B cells. J. Immunol. Res. 2021, 2684361 (2021).
Google Scholar
Tian, G. X. et al. Propionic acid regulates immune tolerant properties in B Cells. J. Cell Mol. Med. 26, 2766–2776 (2022).
Google Scholar
Jiang, S., Yan, W., Wang, S. E. & Baltimore, D. Let-7 suppresses B cell activation through restricting the availability of necessary nutrients. Cell Metab. 27, 393–403.e394 (2018).
Google Scholar
Le, A. et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110–121 (2012).
Google Scholar
Sumikawa, M. H. et al. An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus. Rheumatol. Oxf. 61, 3049–3059 (2022).
Google Scholar
Mielle, J. et al. Glutamine promotes the generation of B10(+) cells via the mTOR/GSK3 pathway. Eur. J. Immunol. 52, 418–430 (2022).
Google Scholar
Wu, M. et al. Glutamine promotes intestinal SIgA secretion through intestinal microbiota and IL-13. Mol. Nutr. Food Res. 60, 1637–1648 (2016).
Google Scholar
Infantino, S. et al. Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation. Nat. Commun. 8, 891 (2017).
Google Scholar
Hata, K. & Mizuguchi, J. Arginine methylation regulates antibody responses through modulating cell division and isotype switching in B cells. Microbiol. Immunol. 57, 185–192 (2013).
Google Scholar
Dagenais-Lussier, X. et al. Latest developments in tryptophan metabolism: understanding its role in B cell immunity. Cytokine Growth Factor Rev. 59, 111–117 (2021).
Google Scholar
Wang, Z. et al. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. Immunity 55, 1067–1081.e1068 (2022).
Google Scholar
Liew, P. X. & Kubes, P. The neutrophil’s role during health and disease. Physiol. Rev. 99, 1223–1248 (2019).
Google Scholar
Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159–175 (2013).
Google Scholar
Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell Mol. Immunol. 19, 177–191 (2022).
Google Scholar
Curi, R. et al. The critical role of cell metabolism for essential neutrophil functions. Cell Physiol. Biochem 54, 629–647 (2020).
Google Scholar
Willson, J. A. et al. Neutrophil HIF-1α stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle. Blood 139, 281–286 (2022).
Google Scholar
You, Z. & Chi, H. Lipid metabolism in dendritic cell biology. Immunol. Rev. 317, 137–151 (2023).
Google Scholar
Macri, C., Pang, E. S., Patton, T. & O’Keeffe, M. Dendritic cell subsets. Semin Cell Dev. Biol. 84, 11–21 (2018).
Google Scholar
Worbs, T., Hammerschmidt, S. I. & Förster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 17, 30–48 (2017).
Google Scholar
Sen, K. et al. NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation. Redox Biol. 59, 102575 (2023).
Google Scholar
Liu, J. et al. CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1α-mediated glycolysis. Immunity 50, 600–615.e615 (2019).
Google Scholar
Basit, F. & de Vries, I. J. M. Dendritic cells require PINK1-mediated phosphorylation of BCKDE1α to promote fatty acid oxidation for immune function. Front. Immunol. 10, 2386 (2019).
Google Scholar
Rehman, A. et al. Role of fatty-acid synthesis in dendritic cell generation and function. J. Immunol. 190, 4640–4649 (2013).
Google Scholar
Goretzki, A. et al. Role of glycolysis and fatty acid synthesis in the activation and T cell-modulating potential of dendritic cells stimulated with a TLR5-ligand allergen fusion protein. Int. J. Mol. Sci. 23, 12695 (2022).
Google Scholar
Herber, D. L. et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat. Med. 16, 880–886 (2010).
Google Scholar
Spits, H. et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).
Google Scholar
Jacquelot, N., Seillet, C., Vivier, E. & Belz, G. T. Innate lymphoid cells and cancer. Nat. Immunol. 23, 371–379 (2022).
Google Scholar
Vivier, E. et al. Innate lymphoid cells: 10 Years On. Cell 174, 1054–1066 (2018).
Google Scholar
Gardiner, C. M. NK cell metabolism. J. Leukoc. Biol. 105, 1235–1242 (2019).
Google Scholar
Pelletier, A. & Stockmann, C. The metabolic basis of ILC plasticity. Front. Immunol. 13, 858051 (2022).
Google Scholar
Cong, J. et al. Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression. Cell Metab. 28, 243–255.e245 (2018).
Google Scholar
Hu, X. et al. Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells. Metabolism 120, 154800 (2021).
Google Scholar
Sheppard, S. et al. Fatty acid oxidation fuels natural killer cell responses against infection and cancer. Proc. Natl Acad. Sci. USA 121, e2319254121 (2024).
Google Scholar
Koh, J. et al. De novo fatty-acid synthesis protects invariant NKT cells from cell death, thereby promoting their homeostasis and pathogenic roles in airway hyperresponsiveness. Elife 12, RP87536 (2023).
Google Scholar
Kobayashi, T. & Mattarollo, S. R. Natural killer cell metabolism. Mol. Immunol. 115, 3–11 (2019).
Google Scholar
Son, S. E., Koh, J. M. & Im, D. S. Free fatty acid receptor 4 (FFA4) activation attenuates obese asthma by suppressing adiposity and resolving metaflammation. Biomed. Pharmacother. 174, 116509 (2024).
Google Scholar
Gury-BenAri, M. et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166, 1231–1246.e1213 (2016).
Google Scholar
Wilhelm, C. et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J. Exp. Med. 213, 1409–1418 (2016).
Google Scholar
Surace, L. et al. Dichotomous metabolic networks govern human ILC2 proliferation and function. Nat. Immunol. 22, 1367–1374 (2021).
Google Scholar
Di Luccia, B. et al. ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands. J. Exp. Med. 216, 2231–2241 (2019).
Google Scholar
Fachi, J. L. et al. Hypoxia enhances ILC3 responses through HIF-1α-dependent mechanism. Mucosal Immunol. 14, 828–841 (2021).
Google Scholar
Golonka, R. M. & Vijay-Kumar, M. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome. Adv. Cancer Res. 149, 171–255 (2021).
Google Scholar
Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635–649 (2016).
Google Scholar
Chang, C. H. et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162, 1229–1241 (2015).
Google Scholar
Dang, Q. et al. Cancer immunometabolism: advent, challenges, and perspective. Mol. Cancer 23, 72 (2024).
Google Scholar
Singer, K. et al. Immunometabolism in cancer at a glance. Dis. Model Mech. 11, dmm034272 (2018).
Google Scholar
Kamarajugadda, S. et al. Glucose oxidation modulates anoikis and tumor metastasis. Mol. Cell Biol. 32, 1893–1907 (2012).
Google Scholar
Lian, X. et al. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy. Mol. Cancer 21, 27 (2022).
Google Scholar
Xu, K. et al. Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses. Immunity 54, 976–987.e977 (2021).
Google Scholar
Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141–162 (2022).
Google Scholar
Mehla, K. & Singh, P. K. Metabolic regulation of macrophage polarization in cancer. Trends Cancer 5, 822–834 (2019).
Google Scholar
Xia, Y. et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv. Mater. 32, e2002054 (2020).
Google Scholar
Morrissey, S. M. et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 33, 2040–2058.e2010 (2021).
Google Scholar
Shi, Q. et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell 40, 1207–1222.e1210 (2022).
Google Scholar
Lu, Y. et al. MondoA-thioredoxin-interacting protein axis maintains regulatory t-cell identity and function in colorectal cancer microenvironment. Gastroenterology 161, 575–591.e516 (2021).
Google Scholar
Hamaidi, I. et al. Sirt2 inhibition enhances metabolic fitness and effector functions of tumor-reactive T cells. Cell Metab. 32, 420–436.e412 (2020).
Google Scholar
He, W. et al. CD155T/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes tumor progression in human gastric cancer. Cancer Res. 77, 6375–6388 (2017).
Google Scholar
Kochenderfer, J. N. & Rosenberg, S. A. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat. Rev. Clin. Oncol. 10, 267–276 (2013).
Google Scholar
Chu, T. W., Kosak, K. M., Shami, P. J. & Kopeček, J. Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cells. Drug Deliv. Transl. Res. 4, 389–394 (2014).
Google Scholar
Simon-Molas, H., Del Prete, R. & Kabanova, A. Glucose metabolism in B cell malignancies: a focus on glycolysis branching pathways. Mol. Oncol. 18, 1777–1794 (2023).
Pi, M. et al. Targeting metabolism to overcome cancer drug resistance: a promising therapeutic strategy for diffuse large B cell lymphoma. Drug. Resist. Updat. 61, 100822 (2022).
Google Scholar
Poulaki, A. & Giannouli, S. Metabolic swifts govern normal and malignant B cell lymphopoiesis. Int. J. Mol. Sci. 22, 8269 (2021).
Google Scholar
Müschen, M. Metabolic gatekeepers to safeguard against autoimmunity and oncogenic B cell transformation. Nat. Rev. Immunol. 19, 337–348 (2019).
Google Scholar
Chen, Z. et al. Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood 140, 630–643 (2022).
Google Scholar
Guo, C. et al. Immunometabolism: a new target for improving cancer immunotherapy. Adv. Cancer Res. 143, 195–253 (2019).
Google Scholar
Su, P. et al. Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res. 80, 1438–1450 (2020).
Google Scholar
Liu, Z. et al. Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. Oncoimmunology 11, 2085432 (2022).
Google Scholar
Huggins, D. N. et al. Characterizing macrophage diversity in metastasis-bearing lungs reveals a lipid-associated macrophage subset. Cancer Res. 81, 5284–5295 (2021).
Google Scholar
Liu, S. et al. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation. J. Immunother. Cancer 9, e002548 (2021).
Google Scholar
Wu, H. et al. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. EMBO Mol. Med. 11, e10698 (2019).
Google Scholar
Masetti, M. et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J. Exp. Med. 219, e20210564 (2022).
Google Scholar
Wang, R., Liu, Z., Fan, Z. & Zhan, H. Lipid metabolism reprogramming of CD8(+) T cell and therapeutic implications in cancer. Cancer Lett. 567, 216267 (2023).
Google Scholar
Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity 54, 1561–1577.e1567 (2021).
Google Scholar
Sun, H. et al. Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. Nat. Commun. 14, 5590 (2023).
Google Scholar
Field, C. S. et al. Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for treg suppressive function. Cell Metab. 31, 422–437.e425 (2020).
Google Scholar
Lim, S. A. et al. Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature 591, 306–311 (2021).
Google Scholar
Yang, F. & Wan, F. Lipid metabolism in tumor-associated B cells. Adv. Exp. Med. Biol. 1316, 133–147 (2021).
Google Scholar
Sun, L. et al. PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells. Leukemia 32, 184–193 (2018).
Google Scholar
Pallasch, C. P. et al. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 22, 585–592 (2008).
Google Scholar
Huang, J. et al. The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism. Biochim. Biophys. Acta 1831, 1555–1565 (2013).
Google Scholar
Sun, Z., Zhang, L. & Liu, L. Reprogramming the lipid metabolism of dendritic cells in tumor immunomodulation and immunotherapy. Biomed. Pharmacother. 167, 115574 (2023).
Google Scholar
Niavarani, S. R. et al. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period. BMC Cancer 19, 823 (2019).
Google Scholar
Tang, W. et al. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver. Cell Mol. Immunol. 19, 834–847 (2022).
Google Scholar
Kobayashi, T. et al. Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood 136, 3004–3017 (2020).
Google Scholar
Li, Z. & Zhang, H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol. Life Sci. 73, 377–392 (2016).
Google Scholar
Yang, L. et al. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy. J. Hematol. Oncol. 16, 59 (2023).
Google Scholar
Liu, J. et al. Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma. Front. Immunol. 13, 960738 (2022).
Google Scholar
Oh, M. H. et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J. Clin. Investig. 130, 3865–3884 (2020).
Google Scholar
Raines, L. N. et al. PERK is a critical metabolic hub for immunosuppressive function in macrophages. Nat. Immunol. 23, 431–445 (2022).
Google Scholar
Edwards, D. N. et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J. Clin. Investig. 131, e140100 (2021).
Google Scholar
Huang, M. et al. Targeting glutamine metabolism to enhance immunoprevention of EGFR-Driven lung cancer. Adv. Sci. 9, e2105885 (2022).
Google Scholar
Kampen, K. R. et al. Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells. Nat. Commun. 10, 2542 (2019).
Google Scholar
Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
Google Scholar
Wang, Z. H. et al. Lactate in the tumour microenvironment: from immune modulation to therapy. EBioMedicine 73, 103627 (2021).
Google Scholar
Jin, M. et al. Tumor-derived lactate creates a favorable niche for tumor via supplying energy source for tumor and modulating the tumor microenvironment. Front. Cell Dev. Biol. 10, 808859 (2022).
Google Scholar
Fang, X. et al. Lactate induces tumor-associated macrophage polarization independent of mitochondrial pyruvate carrier-mediated metabolism. Int. J. Biol. Macromol. 237, 123810 (2023).
Google Scholar
Zhang, A. et al. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17. Theranostics 11, 3839–3852 (2021).
Google Scholar
She, X. et al. SETDB1 Methylates MCT1 promoting tumor progression by enhancing the lactate shuttle. Adv. Sci. 10, e2301871 (2023).
Google Scholar
Vadevoo, S. M. P. et al. The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages. Proc. Natl. Acad. Sci. USA 118, e2102434118 (2021).
Google Scholar
Liu, N. et al. Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression. J. Clin. Investig. 129, 631–646 (2019).
Google Scholar
Yan, C. et al. GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression. J. Exp. Clin. Cancer Res. 43, 105 (2024).
Google Scholar
Oberholtzer, N., Quinn, K. M., Chakraborty, P. & Mehrotra, S. New developments in T Cell immunometabolism and implications for cancer immunotherapy. Cells 11, 708 (2022).
Google Scholar
Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657–671 (2016).
Google Scholar
Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645–651 (2021).
Google Scholar
Anderson, K. G., Stromnes, I. M. & Greenberg, P. D. Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies. Cancer Cell 31, 311–325 (2017).
Google Scholar
Gu, J. et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells. Cell Rep. 39, 110986 (2022).
Google Scholar
Ding, R. et al. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity 57, 528–540.e526 (2024).
Google Scholar
Wang, K., Zhang, Y. & Chen, Z. N. Metabolic interaction: tumor-derived lactate inhibiting CD8(+) T cell cytotoxicity in a novel route. Signal Transduct. Target. Ther. 8, 52 (2023).
Google Scholar
Wang, Z. et al. Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma. Front. Immunol. 14, 894853 (2023).
Google Scholar
Yu, M. & Zhang, S. Influenced tumor microenvironment and tumor immunity by amino acids. Front. Immunol. 14, 1118448 (2023).
Google Scholar
Fu, Q. et al. Tumor-associated macrophage-derived interleukin-23 interlinks kidney cancer glutamine addiction with immune evasion. Eur. Urol. 75, 752–763 (2019).
Google Scholar
Guo, C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620, 200–208 (2023).
Google Scholar
Xiong, J. et al. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential. EBioMedicine 72, 103614 (2021).
Google Scholar
Zhang, Y. et al. Targeted inhibition of the immunoproteasome blocks endothelial MHC class II antigen presentation to CD4(+) T cells in chronic liver injury. Int. Immunopharmacol. 107, 108639 (2022).
Google Scholar
Qin, S. et al. Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration via FGF2. Front. Immunol. 13, 955841 (2022).
Google Scholar
Ma, S. et al. Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos. Sci. Immunol. 9, eadg8817 (2024).
Google Scholar
Morel, L. Immunometabolism in systemic lupus erythematosus. Nat. Rev. Rheumatol. 13, 280–290 (2017).
Google Scholar
Choi, S. C. et al. Immune cell metabolism in systemic lupus erythematosus. Curr. Rheumatol. Rep. 18, 66 (2016).
Google Scholar
Takeshima, Y., Iwasaki, Y., Fujio, K. & Yamamoto, K. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus. Semin. Arthritis Rheum. 48, 1142–1145 (2019).
Google Scholar
Jing, C. et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc. Natl Acad. Sci. USA 117, 15160–15171 (2020).
Google Scholar
Zhao, H., Wen, Z. & Xiong, S. Activated lymphocyte-derived DNA drives glucose metabolic adaptation for inducing macrophage inflammatory response in systemic lupus erythematosus. Cells 12, 2093 (2023).
Google Scholar
Wang, L. X. et al. M2b macrophage polarization and its roles in diseases. J. Leukoc. Biol. 106, 345–358 (2019).
Google Scholar
Li, W. et al. Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters. Front. Immunol. 10, 833 (2019).
Google Scholar
Yin, Y. et al. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J. Immunol. 196, 80–90 (2016).
Google Scholar
Yin, Y. et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7, 274ra218 (2015).
Google Scholar
Abboud, G. et al. Glucose requirement of antigen-specific autoreactive B cells and CD4+ T cells. J. Immunol. 210, 377–388 (2023).
Google Scholar
Scherlinger, M. et al. Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Sci. Adv. 8, eadc9657 (2022).
Google Scholar
Zou, X. et al. Metabolic regulation of follicular helper T cell differentiation in a mouse model of lupus. Immunol. Lett. 247, 13–21 (2022).
Google Scholar
Lin, M. et al. Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice. J. Autoimmun. 145, 103198 (2024).
Google Scholar
Gabriel, C. L. et al. Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus. Am. J. Physiol. Endocrinol. Metab. 303, E1313–E1324 (2012).
Google Scholar
Wang, X. Y. et al. c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Signal Transduct. Target Ther. 7, 105 (2022).
Google Scholar
Sun, W. et al. Lipid Metabolism: immune regulation and therapeutic prospectives in systemic lupus erythematosus. Front. Immunol. 13, 860586 (2022).
Google Scholar
Jaroonwitchawan, T. et al. Dysregulation of lipid metabolism in macrophages is responsible for severe endotoxin tolerance in FcgRIIB-deficient lupus mice. Front. Immunol. 11, 959 (2020).
Google Scholar
Krishnan, S. et al. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172, 7821–7831 (2004).
Google Scholar
Jury, E. C. et al. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J. Clin. Investig. 113, 1176–1187 (2004).
Google Scholar
Zeng, Q. et al. Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses. Cell Metab. 35, 837–854.e838 (2023).
Google Scholar
Kono, M., Yoshida, N. & Tsokos, G. C. Amino acid metabolism in lupus. Front. Immunol. 12, 623844 (2021).
Google Scholar
Kono, M. et al. Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in mrl/lpr mice and experimental autoimmune encephalomyelitis. Arthritis Rheumatol. 71, 1869–1878 (2019).
Google Scholar
Zhang, X. et al. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice. Int. Immunopharmacol. 112, 109133 (2022).
Google Scholar
Sharabi, A., Kasper, I. R. & Tsokos, G. C. The serine/threonine protein phosphatase 2A controls autoimmunity. Clin. Immunol. 186, 38–42 (2018).
Google Scholar
Pan, W. et al. The regulatory subunit PPP2R2A of PP2A Enhances Th1 and Th17 differentiation through activation of the GEF-H1/RhoA/ROCK signaling pathway. J. Immunol. 206, 1719–1728 (2021).
Google Scholar
Crispín, J. C., Apostolidis, S. A., Finnell, M. I. & Tsokos, G. C. Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 108, 12443–12448 (2011).
Google Scholar
Meidan, E. et al. Serine/threonine phosphatase PP2A is essential for optimal B cell function. JCI Insight 5, e130655 (2020).
Google Scholar
Kono, M. et al. Decreased expression of serine/arginine-rich splicing factor 1 in T cells from patients with active systemic lupus erythematosus accounts for reduced expression of RasGRP1 and DNA methyltransferase 1. Arthritis Rheumatol. 70, 2046–2056 (2018).
Google Scholar
Moulton, V. R., Gillooly, A. R. & Tsokos, G. C. Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells. J. Biol. Chem. 289, 4126–4134 (2014).
Google Scholar
Katsuyama, T. et al. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity. J. Clin. Investig. 129, 5411–5423 (2019).
Google Scholar
Katsuyama, T. et al. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus. Rheumatology 59, 2146–2155 (2020).
Google Scholar
Adolph, T. E. et al. The metabolic nature of inflammatory bowel diseases. Nat. Rev. Gastroenterol. Hepatol. 19, 753–767 (2022).
Google Scholar
Zhuang, H. et al. Tiliroside ameliorates ulcerative colitis by restoring the M1/M2 macrophage balance via the HIF-1α/glycolysis pathway. Front. Immunol. 12, 649463 (2021).
Google Scholar
Komuro, M. et al. Glucosylceramide in T cells regulates the pathology of inflammatory bowel disease. Biochem. Biophys. Res. Commun. 599, 24–30 (2022).
Google Scholar
Lee, H., Jeon, J. H. & Kim, E. S. Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease. Front. Immunol. 14, 1219422 (2023).
Google Scholar
Lv, Q. et al. Costunolide ameliorates colitis via specific inhibition of HIF1α/glycolysis-mediated Th17 differentiation. Int. Immunopharmacol. 97, 107688 (2021).
Google Scholar
Lv, Q. et al. Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD(+)/SIRT1/SUV39H1/H3K9me3 signaling pathway. Cell Death Dis. 9, 258 (2018).
Google Scholar
Lu, H. et al. Cyclosporine modulates neutrophil functions via the SIRT6-HIF-1α-glycolysis axis to alleviate severe ulcerative colitis. Clin. Transl. Med. 11, e334 (2021).
Google Scholar
Karaskova, E. et al. Role of adipose tissue in inflammatory bowel disease. Int. J. Mol. Sci. 22, 4226 (2021).
Google Scholar
Xu, J. et al. Inhibition of FABP5 attenuates inflammatory bowel disease by modulating macrophage alternative activation. Biochem. Pharm. 219, 115974 (2024).
Google Scholar
Liang, G. et al. Fatty acid oxidation promotes apoptotic resistance and proinflammatory phenotype of CD4(+) tissue-resident memory t cells in crohn’s disease. Cell Mol. Gastroenterol. Hepatol. 17, 939–964 (2024).
Google Scholar
Li, Y. et al. Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 116, 970–975 (2019).
Google Scholar
Honjo, H. et al. RIPK2 as a new therapeutic target in inflammatory bowel diseases. Front. Pharm. 12, 650403 (2021).
Google Scholar
Parkhouse, R. & Monie, T. P. Dysfunctional crohn’s disease-associated NOD2 polymorphisms Cannot be reliably predicted on the basis of RIPK2 binding or membrane association. Front. Immunol. 6, 521 (2015).
Google Scholar
Lai, Y. et al. Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease. Biochem. Pharm. 214, 115647 (2023).
Google Scholar
Lee, S. H. et al. Inhibition of RIPK3 pathway attenuates intestinal inflammation and cell death of inflammatory bowel disease and suppresses necroptosis in peripheral mononuclear cells of ulcerative colitis patients. Immune Netw. 20, e16 (2020).
Google Scholar
Leber, A. et al. Activation of NLRX1 by NX-13 alleviates inflammatory bowel disease through immunometabolic mechanisms in CD4(+) T cells. J. Immunol. 203, 3407–3415 (2019).
Google Scholar
Liu, Z. et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 12, 1063–1070 (2011).
Google Scholar
Zhou, Z. et al. Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation. Front. Immunol. 13, 966067 (2022).
Google Scholar
Ni, S., Liu, Y., Zhong, J. & Shen, Y. Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis. Bioengineered 13, 8961–8971 (2022).
Google Scholar
Yan, D. et al. Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment. Front. Immunol. 14, 1286667 (2023).
Google Scholar
Sands, B. E. et al. Lipid profiles in patients with ulcerative colitis receiving tofacitinib-implications for cardiovascular risk and patient management. Inflamm. Bowel Dis. 27, 797–808 (2021).
Google Scholar
Qiu, J. et al. Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front. Immunol. 12, 652771 (2021).
Google Scholar
Weyand, C. M. & Goronzy, J. J. Immunometabolism in early and late stages of rheumatoid arthritis. Nat. Rev. Rheumatol. 13, 291–301 (2017).
Google Scholar
Pucino, V. et al. Metabolic checkpoints in rheumatoid arthritis. Front. Physiol. 11, 347 (2020).
Google Scholar
Gan, P. R. et al. Glycolysis, a driving force of rheumatoid arthritis. Int. Immunopharmacol. 132, 111913 (2024).
Google Scholar
Zezina, E., Sercan-Alp, O., Herrmann, M. & Biesemann, N. Glucose transporter 1 in rheumatoid arthritis and autoimmunity. Wiley Interdiscip. Rev. Syst. Biol. Med. 12, e1483 (2020).
Google Scholar
Kim, B. et al. Cytoplasmic zinc promotes IL-1β production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis. Sci. Signal 15, eabi7400 (2022).
Google Scholar
Cai, W. et al. The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner. Mol. Immunol. 140, 186–195 (2021).
Google Scholar
Umar, S. et al. Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types. Cell Mol. Life Sci. 78, 7693–7707 (2021).
Google Scholar
Harshan, S., Dey, P. & Raghunathan, S. Altered transcriptional regulation of glycolysis in circulating cd8(+) t cells of rheumatoid arthritis patients. Genes 13, 1216 (2022).
Google Scholar
Souto-Carneiro, M. M. et al. Effect of increased lactate dehydrogenase a activity and aerobic glycolysis on the proinflammatory profile of autoimmune CD8+ T cells in rheumatoid arthritis. Arthritis Rheumatol. 72, 2050–2064 (2020).
Google Scholar
Zeng, Q. H. et al. B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis. Sci. Adv. 6, eabb6296 (2020).
Google Scholar
Kvacskay, P. et al. Increase of aerobic glycolysis mediated by activated T helper cells drives synovial fibroblasts towards an inflammatory phenotype: new targets for therapy? Arthritis Res. Ther. 23, 56 (2021).
Google Scholar
Suwa, Y., Nagafuchi, Y., Yamada, S. & Fujio, K. The role of dendritic cells and their immunometabolism in rheumatoid arthritis. Front. Immunol. 14, 1161148 (2023).
Google Scholar
Qi, J. et al. IL-27 enhances peripheral B cell glycolysis of rheumatoid arthritis patients via activating mTOR signaling. Int. Immunopharmacol. 121, 110532 (2023).
Google Scholar
Bockermann, R., Schubert, D., Kamradt, T. & Holmdahl, R. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res. Ther. 7, R1316–R1324 (2005).
Google Scholar
Kraus, F. V. et al. Reduction of proinflammatory effector functions through remodeling of fatty acid metabolism in CD8+ T cells from rheumatoid arthritis patients. Arthritis Rheumatol. 75, 1098–1109 (2023).
Google Scholar
Na, H. S. et al. Th17 and IL-17 cause acceleration of inflammation and fat loss by inducing α(2)-glycoprotein 1 (AZGP1) in rheumatoid arthritis with high-fat diet. Am. J. Pathol. 187, 1049–1058 (2017).
Google Scholar
Pucino, V., Bombardieri, M., Pitzalis, C. & Mauro, C. Lactate at the crossroads of metabolism, inflammation, and autoimmunity. Eur. J. Immunol. 47, 14–21 (2017).
Google Scholar
Yi, O. et al. Lactate metabolism in rheumatoid arthritis: Pathogenic mechanisms and therapeutic intervention with natural compounds. Phytomedicine 100, 154048 (2022).
Google Scholar
Pucino, V. et al. Differential effect of lactate on synovial fibroblast and macrophage effector functions. Front. Immunol. 14, 1183825 (2023).
Google Scholar
Pucino, V. et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing Cd4(+) T Cell metabolic rewiring. Cell Metab. 30, 1055–1074.e1058 (2019).
Google Scholar
Haas, R. et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 13, e1002202 (2015).
Google Scholar
Marcus, R. What is multiple sclerosis? JAMA 328, 2078 (2022).
Google Scholar
Oh, J., Vidal-Jordana, A. & Montalban, X. Multiple sclerosis: clinical aspects. Curr. Opin. Neurol. 31, 752–759 (2018).
Google Scholar
Yamout, B. I. & Alroughani, R. Multiple sclerosis. Semin Neurol. 38, 212–225 (2018).
Google Scholar
Kunkl, M. et al. CD28 autonomous signaling up-regulates C-Myc expression and promotes glycolysis enabling inflammatory T cell responses in multiple sclerosis. Cells 8, 575 (2019).
Google Scholar
La Rocca, C. et al. Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration. Metabolism 77, 39–46 (2017).
Google Scholar
Shriver, L. P. & Manchester, M. Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci. Rep. 1, 79 (2011).
Google Scholar
Martin-Gutierrez, L. et al. Dysregulated lipid metabolism networks modulate T-cell function in people with relapsing remitting multiple sclerosis. Clin. Exp. Immunol. 217, 204–218 (2024).
Kamermans, A. et al. Reduced angiopoietin-like 4 expression in multiple sclerosis lesions facilitates lipid uptake by phagocytes via modulation of lipoprotein-lipase activity. Front. Immunol. 10, 950 (2019).
Google Scholar
Werner, P., Pitt, D. & Raine, C. S. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50, 169–180 (2001).
Google Scholar
Chrobok, N. L. et al. Tissue transglutaminase appears in monocytes and macrophages but not in lymphocytes in white matter multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 78, 492–500 (2019).
Google Scholar
van Strien, M. E. et al. Tissue transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration. Brain. Behav. Immun. 50, 141–154 (2015).
Google Scholar
Negrotto, L. & Correale, J. Amino acid catabolism in multiple sclerosis affects immune homeostasis. J. Immunol. 198, 1900–1909 (2017).
Google Scholar
Engin, A. The definition and prevalence of obesity and metabolic syndrome. Adv. Exp. Med. Biol. 960, 1–17 (2017).
Google Scholar
Qi, X. et al. Multifaceted roles of T cells in obesity and obesity-related complications: a narrative review. Obes. Rev. e13621, (2023).
Sharma, M. et al. Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity. Sci. Rep. 10, 5555 (2020).
Google Scholar
Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Investig. 112, 1796–1808 (2003).
Google Scholar
Kawanishi, N., Yano, H., Yokogawa, Y. & Suzuki, K. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 16, 105–118 (2010).
Google Scholar
Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723–737 (2011).
Google Scholar
Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 117, 175–184 (2007).
Google Scholar
Thomas, D. & Apovian, C. Macrophage functions in lean and obese adipose tissue. Metabolism 72, 120–143 (2017).
Google Scholar
Schmidt, V., Hogan, A. E., Fallon, P. G. & Schwartz, C. Obesity-mediated immune modulation: one step forward, (Th)2 steps back. Front. Immunol. 13, 932893 (2022).
Google Scholar
SantaCruz-Calvo, S. et al. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat. Rev. Endocrinol. 18, 23–42 (2022).
Google Scholar
Freemerman, A. J. et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289, 7884–7896 (2014).
Google Scholar
Dror, E. et al. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat. Immunol. 18, 283–292 (2017).
Google Scholar
Hao, S. et al. Goliath induces inflammation in obese mice by linking fatty acid β-oxidation to glycolysis. EMBO Rep. 24, e56932 (2023).
Google Scholar
Ying, W. et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J. Clin. Investig. 127, 1019–1030 (2017).
Google Scholar
Xu, X. et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18, 816–830 (2013).
Google Scholar
Zhang, C. et al. STAT3 activation-induced fatty acid oxidation in CD8(+) T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab. 31, 148–161.e145 (2020).
Google Scholar
Endo, Y. et al. Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1. Cell Rep. 12, 1042–1055 (2015).
Google Scholar
Chen, I. C. et al. High-fat diet-induced obesity alters dendritic cell homeostasis by enhancing mitochondrial fatty acid oxidation. J. Immunol. 209, 69–76 (2022).
Google Scholar
Engin, A. B. Adipocyte-macrophage cross-talk in obesity. Adv. Exp. Med. Biol. 960, 327–343 (2017).
Google Scholar
Eder, K., Baffy, N., Falus, A. & Fulop, A. K. The major inflammatory mediator interleukin-6 and obesity. Inflamm. Res. 58, 727–736 (2009).
Google Scholar
El-Kadre, L. J. & Tinoco, A. C. Interleukin-6 and obesity: the crosstalk between intestine, pancreas and liver. Curr. Opin. Clin. Nutr. Metab. Care 16, 564–568 (2013).
Google Scholar
Bobbo, V. C. et al. Interleukin-6 actions in the hypothalamus protects against obesity and is involved in the regulation of neurogenesis. J. Neuroinflamm. 18, 192 (2021).
Google Scholar
Pacifico, L. et al. Increased T-helper interferon-gamma-secreting cells in obese children. Eur. J. Endocrinol. 154, 691–697 (2006).
Google Scholar
Yarla, N. S., Polito, A. & Peluso, I. Effects of Olive Oil on TNF-α and IL-6 in humans: implication in obesity and frailty. Endocr. Metab. Immune. Disord. Drug Targets 18, 63–74 (2018).
Google Scholar
Wu, P. et al. Serum TNF-α, GTH and MDA of high-fat diet-induced obesity and obesity resistant rats. Saudi Pharm. J. 24, 333–336 (2016).
Google Scholar
Huber, J. et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J. Clin. Endocrinol. Metab. 93, 3215–3221 (2008).
Google Scholar
Kopasov, A. E., Blokhin, S. N., Volkova, E. N. & Morozov, S. G. Chemokine expression in neutrophils and subcutaneous adipose tissue cells obtained during abdominoplasty from patients with obesity and normal body weight. Bull. Exp. Biol. Med. 167, 728–731 (2019).
Google Scholar
Dommel, S. & Blüher, M. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state? Int. J. Mol. Sci. 22, 1500 (2021).
Google Scholar
Ullah, A. et al. A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. Rev. Endocr. Metab. Disord. 24, 611–631 (2023).
Google Scholar
Xia, C., Rao, X. & Zhong, J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J. Diab. Res. 2017, 6494795 (2017).
Ehses, J. A. et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56, 2356–2370 (2007).
Google Scholar
Eguchi, K. & Manabe, I. Macrophages and islet inflammation in type 2 diabetes. Diab. Obes. Metab. 15, 152–158 (2013).
Google Scholar
Kraakman, M. J., Murphy, A. J., Jandeleit-Dahm, K. & Kammoun, H. L. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front. Immunol. 5, 470 (2014).
Google Scholar
Ni, H. X., Yu, N. J. & Yang, X. H. The study of ginsenoside on PPARgamma expression of mononuclear macrophage in type 2 diabetes. Mol. Biol. Rep. 37, 2975–2979 (2010).
Google Scholar
Odegaard, J. I. et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447, 1116–1120 (2007).
Google Scholar
Miya, A. et al. Impact of glucose loading on variations in CD4(+) and CD8(+) T cells in japanese participants with or without type 2 diabetes. Front. Endocrinol. 9, 81 (2018).
Google Scholar
Raphael, I., Nalawade, S., Eagar, T. N. & Forsthuber, T. G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74, 5–17 (2015).
Google Scholar
Li, J. et al. Effect of type 2 diabetes mellitus and periodontitis on the Th1/Th2 and Th17/Treg paradigm. Am. J. Dent. 35, 55–60 (2022).
Google Scholar
Touch, S., Clément, K. & André, S. T cell populations and functions are altered in human obesity and Type 2 diabetes. Curr. Diab Rep. 17, 81 (2017).
Google Scholar
Abdel-Moneim, A., Bakery, H. H. & Allam, G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomed. Pharmacother. 101, 287–292 (2018).
Google Scholar
McLaughlin, T. et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler. Thromb. Vasc. Biol. 34, 2637–2643 (2014).
Google Scholar
Qiao, Y. C. et al. Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J. Diab. Res. 2016, 3694957 (2016).
Matsuura, Y. et al. Diabetes suppresses glucose uptake and glycolysis in macrophages. Circ. Res. 130, 779–781 (2022).
Google Scholar
Nicholas, D. A. et al. Fatty acid metabolites combine with reduced β oxidation to activate Th17 inflammation in human type 2 diabetes. Cell Metab. 30, 447–461.e445 (2019).
Google Scholar
Kristiansen, O. P. & Mandrup-Poulsen, T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54, S114–S124 (2005).
Google Scholar
Akbari, M. & Hassan-Zadeh, V. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26, 685–698 (2018).
Google Scholar
Rehman, K. et al. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Crit. Rev. Eukaryot. Gene Expr. 27, 229–236 (2017).
Google Scholar
Koshino, A. et al. Interleukin-6 and cardiovascular and kidney outcomes in patients with type 2 diabetes: new insights from CANVAS. Diab. Care 45, 2644–2652 (2022).
Google Scholar
Alharby, H. et al. Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes. Cardiovasc. Endocrinol. Metab. 8, 73–76 (2019).
Google Scholar
Yanik, B. M., Dauch, J. R. & Cheng, H. T. Interleukin-10 reduces neurogenic inflammation and pain behavior in a mouse model of type 2 diabetes. J. Pain. Res. 13, 3499–3512 (2020).
Google Scholar
Banerjee, M. & Saxena, M. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clin. Chim. Acta 413, 1163–1170 (2012).
Google Scholar
Maedler, K., Dharmadhikari, G., Schumann, D. M. & Størling, J. Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin. Biol. Ther. 9, 1177–1188 (2009).
Google Scholar
Suri, S. et al. Role of interleukin-2 and interleukin-18 in newly diagnosed type 2 diabetes mellitus. J. Basic Clin. Physiol. Pharm. 33, 185–190 (2021).
Google Scholar
Zaharieva, E. et al. Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. Endocr. Connect. 7, 179–185 (2018).
Google Scholar
Li, L. et al. Association between interleukin-19 and angiopoietin-2 with vascular complications in type 2 diabetes. J. Diab. Investig. 7, 895–900 (2016).
Google Scholar
Gurău, F. et al. Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes. Diab. Res. Clin. Pract. 171, 108585 (2021).
Google Scholar
Nussrat, S. W. & Ad’hiah, A. H. Interleukin-39 is a novel cytokine associated with type 2 diabetes mellitus and positively correlated with body mass index. Endocrinol. Diab. Metab. 6, e409 (2023).
Google Scholar
Halimi, A. et al. The relation between serum levels of interleukin 10 and interferon-gamma with oral candidiasis in type 2 diabetes mellitus patients. BMC Endocr. Disord. 22, 296 (2022).
Google Scholar
Hammad, R. et al. T-Natural killers and interferon gamma/interleukin 4 in augmentation of infection in foot ulcer in type 2 diabetes. Diab. Metab. Syndr. Obes. 14, 1897–1908 (2021).
Google Scholar
Stalenhoef, J. E. et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur. J. Clin. Microbiol. Infect. Dis. 27, 97–103 (2008).
Google Scholar
Syal, K., Srinivasan, A. & Banerjee, D. VDR, RXR, coronin-1 and interferonγ levels in PBMCs of type-2 diabetes patients: molecular link between diabetes and tuberculosis. Indian J. Clin. Biochem. 30, 323–328 (2015).
Google Scholar
Chen, Y. L. et al. Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: a systematic review and meta-analysis. Immunol. Lett. 186, 52–58 (2017).
Google Scholar
Lampropoulou, I. T. et al. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. J. Diab. Res. 2014, 394206 (2014).
Wu, J. et al. Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. Exp. Ther. Med. 6, 1482–1488 (2013).
Google Scholar
Herder, C. et al. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 49, 921–929 (2006).
Google Scholar
Pan, X., Kaminga, A. C., Wen, S. W. & Liu, A. Chemokines in prediabetes and type 2 diabetes: a meta-analysis. Front. Immunol. 12, 622438 (2021).
Google Scholar
Bala, M. et al. Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes. Exp. Clin. Endocrinol. Diab. 119, 370–376 (2011).
Google Scholar
Matsushita, Y. et al. Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients. J. Diab. Investig. 12, 1042–1049 (2021).
Google Scholar
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908–922 (2018).
Google Scholar
Barreby, E., Chen, P. & Aouadi, M. Macrophage functional diversity in NAFLD—more than inflammation. Nat. Rev. Endocrinol. 18, 461–472 (2022).
Google Scholar
Ioannou, G. N. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol. Metab. 27, 84–95 (2016).
Google Scholar
Govaere, O. et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. J. Hepatol. 76, 1001–1012 (2022).
Google Scholar
Mridha, A. R. et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J. Hepatol. 66, 1037–1046 (2017).
Google Scholar
Chatterjee, S. et al. Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis. J. Hepatol. 58, 778–784 (2013).
Google Scholar
Kazankov, K. et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 145–159 (2019).
Google Scholar
Li, J. et al. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice. Int. Immunopharmacol. 88, 106961 (2020).
Google Scholar
Schwabe, R. F., Tabas, I. & Pajvani, U. B. Mechanisms of fibrosis development in nonalcoholic steatohepatitis. Gastroenterology 158, 1913–1928 (2020).
Google Scholar
Mao, T., Yang, R., Luo, Y. & He, K. Crucial role of T cells in NAFLD-related disease: a review and prospect. Front Endocrinol. 13, 1051076 (2022).
Google Scholar
Belikov, A. V., Schraven, B. & Simeoni, L. T cells and reactive oxygen species. J. Biomed. Sci. 22, 85 (2015).
Google Scholar
Chávez, M. D. & Tse, H. M. Targeting mitochondrial-derived reactive oxygen species in T cell-mediated autoimmune diseases. Front. Immunol. 12, 703972 (2021).
Google Scholar
Racanelli, V. & Rehermann, B. The liver as an immunological organ. Hepatology 43, S54–S62 (2006).
Google Scholar
Deng, C. J. et al. Role of B lymphocytes in the pathogenesis of NAFLD: a 2022 update. Int. J. Mol. Sci. 23, (2022).
Barrow, F. et al. Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling. Hepatology 74, 704–722 (2021).
Google Scholar
Miyake, T. et al. B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease. Hepatol. Int 7, 539–547 (2013).
Google Scholar
Kanemitsu-Okada, K. et al. Role of B cell-activating factor in fibrosis progression in a murine model of non-alcoholic steatohepatitis. Int. J. Mol. Sci. 24, 2509 (2023).
Barrow, F., Khan, S., Wang, H. & Revelo, X. S. The emerging role of B cells in the pathogenesis of NAFLD. Hepatology 74, 2277–2286 (2021).
Google Scholar
Bruzzì, S. et al. B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD). Free Radic. Biol. Med. 124, 249–259 (2018).
Google Scholar
Schmidt-Arras, D. & Rose-John, S. IL-6 pathway in the liver: from physiopathology to therapy. J. Hepatol. 64, 1403–1415 (2016).
Google Scholar
Drummer, C. 4th et al. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. Front. Immunol. 14, 1113883 (2023).
Google Scholar
Inomata, Y. et al. Downregulation of miR-122-5p activates glycolysis via PKM2 in Kupffer cells of rat and mouse models of non-alcoholic steatohepatitis. Int. J. Mol. Sci. 23, 5230 (2022).
Google Scholar
Dong, T. et al. Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. Nat. Commun. 15, 807 (2024).
Google Scholar
Fan, N. et al. Covalent Inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease. Int. J. Biol. Sci. 18, 5260–5275 (2022).
Google Scholar
Darmadi, D. & Ruslie, R. H. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Rom. J. Intern. Med. 59, 66–72 (2021).
Google Scholar
Baselli, G. A. et al. Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut 69, 1855–1866 (2020).
Google Scholar
Cao, J. et al. Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease. Lipids Health Dis. 21, 70 (2022).
Google Scholar
Wieckowska, A. et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103, 1372–1379 (2008).
Google Scholar
Widjaja, A. A. et al. Inhibiting Interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis. Gastroenterology 157, 777–792.e714 (2019).
Google Scholar
Cook, S. A. & Schafer, S. Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation. Annu. Rev. Med. 71, 263–276 (2020).
Google Scholar
Li, S., Chen, L. & Lv, G. Interleukin-6 receptor blockade can increase the risk of nonalcoholic fatty liver disease: indications from mendelian randomization. Front. Pharm. 13, 905936 (2022).
Google Scholar
He, S. et al. Interleukin-17 weakens the NAFLD/NASH process by facilitating intestinal barrier restoration depending on the gut microbiota. mBio 13, e0368821 (2022).
Google Scholar
Gomes, A. L. et al. Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Cell 30, 161–175 (2016).
Google Scholar
Hwang, S. et al. Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets. Hepatology 72, 412–429 (2020).
Google Scholar
Ghazarian, M. et al. Type I interferon responses drive intrahepatic t cells to promote metabolic syndrome. Sci. Immunol. 2, eaai7616 (2017).
Møhlenberg, M. et al. The presence of interferon affects the progression of non-alcoholic fatty liver disease. Genes Immun. 23, 157–165 (2022).
Google Scholar
Wieser, V. et al. Adipose type I interferon signalling protects against metabolic dysfunction. Gut 67, 157–165 (2018).
Google Scholar
Kakino, S. et al. Pivotal role of TNF-α in the development and progression of nonalcoholic fatty liver disease in a murine model. Horm. Metab. Res. 50, 80–87 (2018).
Google Scholar
Tiegs, G. & Horst, A. K. TNF in the liver: targeting a central player in inflammation. Semin. Immunopathol. 44, 445–459 (2022).
Google Scholar
Wandrer, F. et al. TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death Dis. 11, 212 (2020).
Google Scholar
Morikawa, R. et al. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. J. Hepatol. 74, 511–521 (2021).
Google Scholar
Kriss, M. et al. Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development. PLoS One 15, e0236353 (2020).
Google Scholar
Xu, L., Kitade, H., Ni, Y. & Ota, T. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease. Biomolecules 5, 1563–1579 (2015).
Google Scholar
Roh, Y. S. & Seki, E. Chemokines and chemokine receptors in the development of NAFLD. Adv. Exp. Med. Biol. 1061, 45–53 (2018).
Google Scholar
Chen, W., Zhang, J., Fan, H. N. & Zhu, J. S. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. Ther. Adv. Gastroenterol. 11, 1756284818815184 (2018).
Google Scholar
Braunersreuther, V., Viviani, G. L., Mach, F. & Montecucco, F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J. Gastroenterol. 18, 727–735 (2012).
Google Scholar
Xu, L. et al. CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice. Metabolism 125, 154914 (2021).
Google Scholar
Hanson, A. et al. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p. Cytokine 123, 154789 (2019).
Google Scholar
Fan, Z. et al. C-C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease. JHEP Rep. 5, 100805 (2023).
Google Scholar
Qi, J. et al. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice. Int. Immunopharmacol. 123, 110752 (2023).
Google Scholar
Zou, Y. et al. CXCL6 promotes the progression of NAFLD through regulation of PPARα. Cytokine 174, 156459 (2024).
Google Scholar
Zhou, C. et al. FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression. Biochim. Biophys. Acta Mol. Basis Dis. 1869, 166810 (2023).
Google Scholar
Russell, D. G., Huang, L. & VanderVen, B. C. Immunometabolism at the interface between macrophages and pathogens. Nat. Rev. Immunol. 19, 291–304 (2019).
Google Scholar
Li, C. et al. HIF1α-dependent glycolysis promotes macrophage functional activities in protecting against bacterial and fungal infection. Sci. Rep. 8, 3603 (2018).
Google Scholar
Lacey, C. A. et al. MyD88-dependent glucose restriction and itaconate production control brucella infection. Infect. Immun. 89, e0015621 (2021).
Google Scholar
Rahman, A. N. et al. Elevated glycolysis imparts functional ability to CD8(+) T cells in HIV infection. Life Sci. Alliance 4, e202101081 (2021).
Google Scholar
Kavanagh Williamson, M. et al. Upregulation of glucose uptake and hexokinase activity of primary human CD4+ T cells in response to infection with HIV-1. Viruses 10, 114 (2018).
Google Scholar
Clerc, I. et al. Entry of glucose- and glutamine-derived carbons into the citric acid cycle supports early steps of HIV-1 infection in CD4 T cells. Nat. Metab. 1, 717–730 (2019).
Google Scholar
Sun, Z. et al. CD160 Promotes NK cell functions by upregulating glucose metabolism and negatively correlates With HIV disease progression. Front. Immunol. 13, 854432 (2022).
Google Scholar
Modi, N. et al. BRD4 regulates glycolysis-dependent Nos2 expression in macrophages upon H pylori infection. Cell Mol. Gastroenterol. Hepatol. 17, 292–308.e291 (2024).
Google Scholar
Codo, A. C. et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a hif-1α/glycolysis-dependent axis. Cell Metab. 32, 437–446.e435 (2020).
Google Scholar
Stüve, P. et al. De novo fatty acid synthesis during mycobacterial infection is a prerequisite for the function of highly proliferative T cells, but not for dendritic cells or macrophages. Front. Immunol. 9, 495 (2018).
Google Scholar
Ibitokou, S. A. et al. Early inhibition of fatty acid synthesis reduces generation of memory precursor effector T cells in chronic infection. J. Immunol. 200, 643–656 (2018).
Google Scholar
Matsushita, M. et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212, 555–568 (2015).
Google Scholar
Karinch, A. M. et al. Glutamine metabolism in sepsis and infection. J. Nutr. 131, 2535S–2538S (2001). discussion 2550S-2531S.
Google Scholar
Jiang, Q. et al. Glutamine is required for M1-like polarization of macrophages in response to Mycobacterium tuberculosis infection. mBio 13, e0127422 (2022).
Google Scholar
Koeken, V. et al. Role of glutamine metabolism in host defense against mycobacterium tuberculosis infection. J. Infect. Dis. 219, 1662–1670 (2019).
Google Scholar
DeBerge, M., Chaudhary, R., Schroth, S. & Thorp, E. B. Immunometabolism at the heart of cardiovascular disease. JACC Basic Transl. Sci. 8, 884–904 (2023).
Google Scholar
Gaddis, D. E. et al. Atherosclerosis impairs naive CD4 T-cell responses via disruption of glycolysis. Arterioscler Thromb. Vasc. Biol. 41, 2387–2398 (2021).
Google Scholar
Li, L. et al. Calenduloside e modulates macrophage polarization via KLF2-regulated glycolysis, contributing to attenuates atherosclerosis. Int. Immunopharmacol. 117, 109730 (2023).
Google Scholar
Zhao, M. et al. Salvianolic acid B regulates macrophage polarization in ischemic/reperfused hearts by inhibiting mTORC1-induced glycolysis. Eur. J. Pharm. 871, 172916 (2020).
Google Scholar
Mouton, A. J. et al. Temporal changes in glucose metabolism reflect polarization in resident and monocyte-derived macrophages after myocardial infarction. Front. Cardiovasc. Med. 10, 1136252 (2023).
Google Scholar
Yuan, Y., Li, P. & Ye, J. Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell 3, 173–181 (2012).
Google Scholar
Sukhorukov, V. N. et al. Lipid metabolism in macrophages: focus on atherosclerosis. Biomedicines. 8, 262 (2020).
Huangfu, N. et al. TDP43 exacerbates atherosclerosis progression by promoting inflammation and lipid uptake of macrophages. Front. Cell Dev. Biol. 9, 687169 (2021).
Google Scholar
Cao, D. et al. Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism. Cardiovasc. Res. 119, 1825–1841 (2023).
Google Scholar
Nomura, M. et al. Macrophage fatty acid oxidation inhibits atherosclerosis progression. J. Mol. Cell Cardiol. 127, 270–276 (2019).
Google Scholar
Paulson, K. E. et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 106, 383–390 (2010).
Google Scholar
Zhang, X. et al. Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk. Nat. Metab. 6, 359–377 (2024).
Google Scholar
Rose, A. J. & Rusu, P. M. A leucine-macrophage mTORC1 connection drives increased risk of atherosclerosis with high-protein diets. Nat. Metab. 6, 203–204 (2024).
Google Scholar
Nayak, D., Roth, T. L. & McGavern, D. B. Microglia development and function. Annu. Rev. Immunol. 32, 367–402 (2014).
Google Scholar
Shippy, D. C. & Ulland, T. K. Microglial Immunometabolism in Alzheimer’s disease. Front. Cell Neurosci. 14, 563446 (2020).
Google Scholar
Hsieh, S. W. et al. M2b macrophage subset decrement as an indicator of cognitive function in Alzheimer’s disease. Psychiatry Clin. Neurosci. 74, 383–391 (2020).
Google Scholar
Pan, R. Y. et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer’s disease. Cell Metab. 34, 634–648.e636 (2022).
Google Scholar
Xiang, X. et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci. Transl. Med. 13, eabe5640 (2021).
Google Scholar
Tondo, G. et al. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease. Alzheimers Res. Ther. 12, 50 (2020).
Google Scholar
Shippy, D. C. & Ulland, T. K. Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation. Sci. Rep. 13, 14800 (2023).
Google Scholar
Xu, J. et al. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s disease. Transl. Neurodegener. 9, 36 (2020).
Google Scholar
Claes, C. et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer’s disease. Mol. Neurodegener. 16, 50 (2021).
Google Scholar
Podleśny-Drabiniok, A. et al. BHLHE40/41 regulate microglia and peripheral macrophage responses associated with Alzheimer’s disease and other disorders of lipid-rich tissues. Nat. Commun. 15, 2058 (2024).
Google Scholar
Hu, X., Ma, Y. N. & Xia, Y. Association between abnormal lipid metabolism and Alzheimer’s disease: new research has revealed significant findings on the APOE4 genotype in microglia. Biosci. Trends 18,195–197 (2024).
Beltrán-Castillo, S., Eugenín, J. & von Bernhardi, R. Impact of aging in microglia-mediated D-serine balance in the CNS. Mediators Inflamm. 2018, 7219732 (2018).
Google Scholar
Wu, S. Z. et al. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J. Neuroinflamm. 1, 2 (2004).
Google Scholar
Nakajima, K., Kanamatsu, T., Takezawa, Y. & Kohsaka, S. Up-regulation of glutamine synthesis in microglia activated with endotoxin. Neurosci. Lett. 591, 99–104 (2015).
Google Scholar
Zhong, W. J. et al. TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury. Int. J. Biol. Sci. 19, 242–257 (2023).
Google Scholar
Zhang, Y. et al. Paraquat promotes acute lung injury in rats by regulating alveolar macrophage polarization through glycolysis. Ecotoxicol. Environ. Saf. 223, 112571 (2021).
Google Scholar
Chen, D. L. et al. Increased T cell glucose uptake reflects acute rejection in lung grafts. Am. J. Transpl. 13, 2540–2549 (2013).
Google Scholar
Liao, F. et al. Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury. Am. J. Transplant. 24,1382–1394 (2024).
Qin, H. et al. Targeting CXCR1 alleviates hyperoxia-induced lung injury through promoting glutamine metabolism. Cell Rep. 42, 112745 (2023).
Google Scholar
Vigeland, C. L. et al. Inhibition of glutamine metabolism accelerates resolution of acute lung injury. Physiol. Rep. 7, e14019 (2019).
Google Scholar
Zhang, Y. et al. Glycine attenuates lipopolysaccharide-induced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling. Nutrients. 12, 611 (2020).
Cheng, S. C. et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).
Google Scholar
Rashid, M. et al. Up-down regulation of HIF-1α in cancer progression. Gene 798, 145796 (2021).
Google Scholar
Meng, Y. et al. Histone methyltransferase SETD2 inhibits M1 macrophage polarization and glycolysis by suppressing HIF-1α in sepsis-induced acute lung injury. Med. Microbiol. Immunol. 212, 369–379 (2023).
Google Scholar
Hao, H. et al. HIF-1α promotes astrocytic production of macrophage migration inhibitory factor following spinal cord injury. CNS Neurosci. Ther. 29, 3802–3814 (2023).
Google Scholar
Wu, M. M. et al. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization. Pharm. Res. 172, 105796 (2021).
Google Scholar
Yuan, Y. et al. Adipose-derived mesenchymal stem cells reprogram M1 macrophage metabolism via PHD2/HIF-1α pathway in colitis mice. Front. Immunol. 13, 859806 (2022).
Google Scholar
Cheng, Y. et al. Autologous blood transfusion impedes glycolysis in macrophages to inhibit red blood cell injury in type 2 diabetes through PI3K/Akt/PKM2 signaling axis. Acta Diabetol. 60, 481–492 (2023).
Google Scholar
Du, N. et al. N-phenethyl-5-phenylpicolinamide alleviates inflammation in acute lung injury by inhibiting HIF-1α/glycolysis/ASIC1a pathway. Life Sci. 309, 120987 (2022).
Google Scholar
Tao, X., Yin, L., Xu, L. & Peng, J. Dioscin: a diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections. Pharm. Res. 137, 259–269 (2018).
Google Scholar
Zhang, Z. et al. PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review). Mol. Med. Rep. 18, 3547–3554 (2018).
Google Scholar
Jang, H. J. et al. Nectandrin B-mediated activation of the AMPK pathway prevents cellular senescence in human diploid fibroblasts by reducing intracellular ROS levels. Aging 11, 3731–3749 (2019).
Google Scholar
Wang, J. Z. et al. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun. 41, 560–575 (2021).
Google Scholar
Dayton, T. L., Jacks, T. & Vander Heiden, M. G. PKM2, cancer metabolism, and the road ahead. EMBO Rep. 17, 1721–1730 (2016).
Google Scholar
Hu, X. et al. PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab. Investig. 100, 801–811 (2020).
Google Scholar
He, Q., Yin, J., Zou, B. & Guo, H. WIN55212-2 alleviates acute lung injury by inhibiting macrophage glycolysis through the miR-29b-3p/FOXO3/PFKFB3 axis. Mol. Immunol. 149, 119–128 (2022).
Google Scholar
Zhai, G. Y. et al. sDR5-Fc inhibits macrophage M1 polarization by blocking the glycolysis. J. Geriatr. Cardiol. 18, 271–280 (2021).
Google Scholar
Songyang, Y. et al. The inhibition of GLUT1-induced glycolysis in macrophage by phloretin participates in the protection during acute lung injury. Int. Immunopharmacol. 110, 109049 (2022).
Google Scholar
Abboud, G. et al. Inhibition of glycolysis reduces disease severity in an autoimmune model of rheumatoid arthritis. Front. Immunol. 9, 1973 (2018).
Google Scholar
Surendar, J. et al. Adiponectin limits IFN-γ and IL-17 producing CD4 T cells in obesity by restraining cell intrinsic glycolysis. Front. Immunol. 10, 2555 (2019).
Google Scholar
Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121–135 (2018).
Google Scholar
Foretz, M. et al. Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953–966 (2014).
Google Scholar
Rose, S. et al. Regulatory T cells and bioenergetics of peripheral blood mononuclear cells linked to pediatric obesity. Immunometabolism 6, e00040 (2024).
Google Scholar
Laussel, C. & Léon, S. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms. Biochem. Pharm. 182, 114213 (2020).
Google Scholar
Kang, H. T. & Hwang, E. S. 2-Deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic. Life Sci. 78, 1392–1399 (2006).
Google Scholar
Zhong, W. J. et al. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model. J. Cell Physiol. 234, 4641–4654 (2019).
Google Scholar
Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013–1021 (2019).
Google Scholar
Wiel, C. et al. BACH1 stabilization by antioxidants stimulates lung cancer metastasis. Cell 178, 330–345.e322 (2019).
Google Scholar
Guo, D. et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metab. 34, 1312–1324.e1316 (2022).
Google Scholar
Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T Cells. Immunity 44, 712 (2016).
Google Scholar
Hinshaw, D. C. et al. Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages. Cancer Res. 81, 5425–5437 (2021).
Google Scholar
Hermans, D. et al. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8(+) T cell stemness and antitumor immunity. Proc. Natl Acad. Sci. USA 117, 6047–6055 (2020).
Google Scholar
Inamdar, S. et al. Rescue of dendritic cells from glycolysis inhibition improves cancer immunotherapy in mice. Nat. Commun. 14, 5333 (2023).
Google Scholar
Sekulic, A. et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl. J. Med. 366, 2171–2179 (2012).
Google Scholar
Kalyanaraman, B., Cheng, G., Hardy, M. & You, M. OXPHOS-targeting drugs in oncology: new perspectives. Expert Opin. Ther. Targets 27, 939–952 (2023).
Google Scholar
Donati, G. et al. Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma. EMBO Mol. Med. 15, e16910 (2023).
Google Scholar
Purhonen, J., Klefström, J. & Kallijärvi, J. MYC-an emerging player in mitochondrial diseases. Front. Cell Dev. Biol. 11, 1257651 (2023).
Google Scholar
Xiao, G. et al. B-Cell-specific diversion of glucose carbon utilization reveals a unique vulnerability in B cell malignancies. Cell 173, 470–484.e418 (2018).
Google Scholar
Hu, J. et al. WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. Haematologica 106, 1816–1827 (2021).
Google Scholar
Yang, Y. et al. Mitochondrial UQCC3 modulates hypoxia adaptation by orchestrating OXPHOS and glycolysis in hepatocellular carcinoma. Cell Rep. 33, 108340 (2020).
Google Scholar
Verstockt, B. et al. The safety, tolerability, pharmacokinetics and clinical efficacy of the NLRX1 agonist NX-13 in active ulcerative colitis: results of a phase 1b study. J. Crohns Colitis, 18, 762–772 (2023).
Kawalekar, O. U. et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T Cells. Immunity 44, 380–390 (2016).
Google Scholar
Whelan, J. & Fritsche, K. Linoleic acid. Adv. Nutr. 4, 311–312 (2013).
Google Scholar
Alarcon-Gil, J. et al. Neuroprotective and anti-inflammatory effects of linoleic acid in models of parkinson’s disease: the implication of lipid droplets and lipophagy. Cells. 11, 229 (2022).
Mercola, J. & D’Adamo, C. R. Linoleic acid: a narrative review of the effects of increased intake in the standard american diet and associations with chronic disease. Nutrients. 15, 3129 (2023).
Hildreth, K., Kodani, S. D., Hammock, B. D. & Zhao, L. Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies. J. Nutr. Biochem 86, 108484 (2020).
Google Scholar
Nava Lauson, C. B. et al. Linoleic acid potentiates CD8(+) T cell metabolic fitness and antitumor immunity. Cell Metab. 35, 633–650.e639 (2023).
Google Scholar
Ma, K. et al. Hepatocellular carcinoma LINC01116 outcompetes T cells for linoleic acid and accelerates tumor progression. Adv. Sci., e2400676, (2024).
Liu, P. S. et al. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat. Immunol. 24, 452–462 (2023).
Google Scholar
An, L. et al. Qingfei oral liquid alleviates RSV-induced lung inflammation by promoting fatty-acid-dependent M1/M2 macrophage polarization via the Akt signaling pathway. J. Ethnopharmacol. 298, 115637 (2022).
Google Scholar
Afonso, M. B. et al. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. Gut 70, 2359–2372 (2021).
Google Scholar
Xu, M. et al. Activated TNF-α/RIPK3 signaling is involved in prolonged high fat diet-stimulated hepatic inflammation and lipid accumulation: inhibition by dietary fisetin intervention. Food Funct. 10, 1302–1316 (2019).
Google Scholar
Schlaepfer, I. R. & Joshi, M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology 161, bqz046 (2020).
Bougarne, N. et al. Molecular actions of PPARα in lipid metabolism and inflammation. Endocr. Rev. 39, 760–802 (2018).
Google Scholar
Wang, D. et al. Fibrates for secondary prevention of cardiovascular disease and stroke. Cochrane Database Syst. Rev. 2015, Cd009580 (2015).
Google Scholar
Vonderheide, R. H. CD40 agonist antibodies in cancer immunotherapy. Annu. Rev. Med. 71, 47–58 (2020).
Google Scholar
Fleischmann, R. et al. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis. N. Engl. J. Med. 367, 495–507 (2012).
Google Scholar
Sandborn, W. J. et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 376, 1723–1736 (2017).
Google Scholar
Mease, P. et al. Tofacitinib or adalimumab versus placebo for psoriatic arthritis. N. Engl. J. Med. 377, 1537–1550 (2017).
Google Scholar
Pérez-Baos, S. et al. Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis. Br. J. Pharm. 174, 3018–3031 (2017).
Google Scholar
Barrera, G., Pizzimenti, S. & Dianzani, M. U. Lipid peroxidation: control of cell proliferation, cell differentiation and cell death. Mol. Asp. Med. 29, 1–8 (2008).
Google Scholar
Liu, J. et al. Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization. Redox Biol. 56, 102452 (2022).
Google Scholar
Lai, Z. W. et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64, 2937–2946 (2012).
Google Scholar
Li, M. et al. Early-stage lupus nephritis treated with N-acetylcysteine: a report of two cases. Exp. Ther. Med. 10, 689–692 (2015).
Google Scholar
Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 619–634 (2016).
Google Scholar
Cluntun, A. A., Lukey, M. J., Cerione, R. A. & Locasale, J. W. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer 3, 169–180 (2017).
Google Scholar
Hensley, C. T., Wasti, A. T. & DeBerardinis, R. J. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J. Clin. Investig. 123, 3678–3684 (2013).
Google Scholar
Martinez-Outschoorn, U. E. et al. Cancer metabolism: a therapeutic perspective. Nat. Rev. Clin. Oncol. 14, 11–31 (2017).
Google Scholar
Sbirkov, Y. et al. Targeting glutaminolysis shows efficacy in both prednisolone-sensitive and in metabolically rewired prednisolone-resistant b-cell childhood acute lymphoblastic leukaemia cells. Int. J. Mol. Sci. 24, 3378 (2023).
Tang, Y. et al. Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer. J. Nanobiotechnol. 20, 216 (2022).
Google Scholar
Huang, R. et al. Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer. Front. Immunol. 14, 1251643 (2023).
Google Scholar
Pillai, R. et al. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Sci. Adv. 10, eadm9859 (2024).
Google Scholar
Sugimoto, K. et al. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines. Cancer Sci. 106, 1534–1543 (2015).
Google Scholar
Liu, N. et al. Eubacterium rectale improves the efficacy of anti-PD1 immunotherapy in melanoma via l-serine-mediated NK cell activation. Research 6, 0127 (2023).
Google Scholar
Liu, Y. et al. Lycorine eliminates B-cell acute lymphoblastic leukemia cells by targeting PSAT1 through the serine/glycine metabolic pathway. Eur. J. Pharm. 961, 176162 (2023).
Google Scholar
Apostolova, P. & Pearce, E. L. Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment. Trends Immunol. 43, 969–977 (2022).
Google Scholar
Ma, J. et al. Lithium carbonate revitalizes tumor-reactive CD8(+) T cells by shunting lactic acid into mitochondria. Nat. Immunol. 25, 552–561 (2024).
Google Scholar
Plitzko, B. & Loesgen, S. Measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in culture cells for assessment of the energy metabolism. Bio Protoc. 8, e2850 (2018).
Google Scholar
Sakamuru, S., Attene-Ramos, M. S. & Xia, M. Mitochondrial membrane potential assay. Methods Mol. Biol. 1473, 17–22 (2016).
Google Scholar
McGarry, T. et al. Rheumatoid arthritis CD14(+) monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease. Clin. Transl. Immunol. 10, e1237 (2021).
Google Scholar
Grayson, P. C. et al. Metabolic pathways and immunometabolism in rare kidney diseases. Ann. Rheum. Dis. 77, 1226–1233 (2018).
Google Scholar
Shinohara, S., Hirohata, S., Inoue, T. & Ito, K. Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritis. J. Rheumatol. 19, 211–215 (1992).
Google Scholar
Chen, S. et al. Peripheral blood monocytes predict clinical prognosis and support tumor invasiveness through NF-κB-dependent upregulation of Snail in pancreatic cancer. Transl. Cancer Res. 10, 4773–4785 (2021).
Google Scholar
Wu, Y. et al. Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients. BMC Cancer 20, 173 (2020).
Google Scholar
Tang, L., Ye, J., Shi, Y. & Zhu, X. Association between CD16(++) monocytes in peripheral blood and clinical features and short-term therapeutic effects of polycystic ovary syndrome. Int J. Gynaecol. Obstet. 145, 12–17 (2019).
Google Scholar
Artyomov, M. N. & Van den Bossche, J. Immunometabolism in the Single-Cell Era. Cell Metab. 32, 710–725 (2020).
Google Scholar
Vreijling, S. R. et al. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials. Br. J. Psychiatry 224, 89–97 (2024).
Google Scholar
Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).
Google Scholar
Oo, Y. H. et al. Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis. JHEP Rep. 1, 286–296 (2019).
Google Scholar
Galli, F. et al. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy. J. Exp. Clin. Cancer Res. 39, 89 (2020).
Google Scholar
Xiao, C. et al. Immunometabolism: a new dimension in immunotherapy resistance. Front. Med. 17, 585–616 (2023).
Google Scholar
Clarke, A. J. et al. B1a B cells require autophagy for metabolic homeostasis and self-renewal. J. Exp. Med. 215, 399–413 (2018).
Google Scholar
Zhou, Y. et al. Xanthones from Securidaca inappendiculata Hassk. attenuate collagen-induced arthritis in rats by inhibiting the nicotinamide phosphoribosyltransferase/glycolysis pathway and macrophage polarization. Int. Immunopharmacol. 111, 109137 (2022).
Google Scholar
Jiang, W. et al. Peficitinib alleviated acute lung injury by blocking glycolysis through JAK3/STAT3 pathway. Int. Immunopharmacol. 132, 111931 (2024).
Google Scholar
link
.jpg "The Best Zinc-Rich Foods to Support Your Immune System")
